ANTHONY MARESSO to Urinary Tract Infections
This is a "connection" page, showing publications ANTHONY MARESSO has written about Urinary Tract Infections.
Connection Strength
2.662
-
Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. Int J Antimicrob Agents. 2025 Dec; 66(6):107613.
Score: 0.674
-
The rise, fall, and resurgence of phage therapy for urinary tract infection. EcoSal Plus. 2024 Dec 12; 12(1):eesp00292023.
Score: 0.600
-
Broad protective vaccination against systemic Escherichia coli with autotransporter antigens. PLoS Pathog. 2023 02; 19(2):e1011082.
Score: 0.564
-
Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection. Viruses. 2021 10 12; 13(10).
Score: 0.514
-
Bacteriophage-mediated reduction of uropathogenic E. coli from the urogenital epithelium. Infect Immun. 2026 Apr 15; 94(4):e0054325.
Score: 0.174
-
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment. mSphere. 2022 08 31; 7(4):e0034522.
Score: 0.136